Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

p53 phase II trial for head and neck cancer

Sep. 24, 1997

Micrologix Biotech and BCCA expand research for anticancer agents

Sep. 24, 1997

BioChem Therapeutic synthesizes antiangiogenic fumagillin analogues

Sep. 24, 1997

More new taxoids from Rhone-Poulenc Rorer

Sep. 24, 1997

Protein farnesyltransferase inhibitors prepared at Schering-Plough

Sep. 24, 1997

NCI to fund clinical trials of Pharmacyclics' Gd-Tex

Sep. 22, 1997

FDA panel recommends approval of Paxene

Sep. 22, 1997

Vaccine for colorectal cancer enters phase I/II

Sep. 22, 1997

Scotia signs licensing agreements for Foscan

Sep. 22, 1997

NCI sponsors trials of new treatment for MDR in multiple myeloma

Sep. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...